Skip to content
TrialScanner

NCT02840110

Long-Term Follow-Up Study of Subjects Treated With ACTR T Cell Product

No phase registeredTerminatedCOGTLead

Registry record

Lead sponsor
Cogent Biosciences, Inc.
Conditions
B Cell Lymphomas; Multiple Myeloma; Solid Tumor; HER-2 Protein Overexpression
Primary completion
Oct 23, 2020Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT02840110 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT02840110: Long-Term Follow-Up Study of... | TrialScanner